Dyne Therapeutics, Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2025-02-27: Form 10-K; Item Well-known seasoned issuer; As filed No.
- 2024-11-12: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2024-11-12: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2024-08-12: Form 10-Q; Item Smaller reporting company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2025-02-27 | 10-K | Well-known seasoned issuer | No |
| 2024-11-12 | 10-Q | Smaller reporting company | Yes |
| 2024-11-12 | 10-Q | Emerging growth company | Yes |
| 2024-08-12 | 10-Q | Smaller reporting company | Yes |
| 2024-08-12 | 10-Q | Emerging growth company | Yes |
| 2024-05-02 | 10-Q | Smaller reporting company | Yes |
| 2024-05-02 | 10-Q | Emerging growth company | Yes |
| 2024-03-05 | 10-K | Smaller reporting company | Yes |
| 2024-03-05 | 10-K | Emerging growth company | Yes |
| 2024-03-05 | 10-K | Well-known seasoned issuer | No |
| 2023-10-30 | 10-Q | Smaller reporting company | Yes |
| 2023-10-30 | 10-Q | Emerging growth company | Yes |
| 2023-08-03 | 10-Q | Smaller reporting company | Yes |
| 2023-08-03 | 10-Q | Emerging growth company | Yes |
| 2023-05-11 | 10-Q | Smaller reporting company | Yes |
| 2023-05-11 | 10-Q | Emerging growth company | Yes |
| 2023-03-02 | 10-K | Smaller reporting company | Yes |
| 2023-03-02 | 10-K | Emerging growth company | Yes |
| 2023-03-02 | 10-K | Well-known seasoned issuer | No |
| 2022-11-03 | 10-Q | Smaller reporting company | Yes |
| 2022-11-03 | 10-Q | Emerging growth company | Yes |
| 2022-08-04 | 10-Q | Smaller reporting company | Yes |
| 2022-08-04 | 10-Q | Emerging growth company | Yes |
| 2022-05-02 | 10-Q | Smaller reporting company | Yes |
| 2022-05-02 | 10-Q | Emerging growth company | Yes |
| 2022-03-10 | 10-K | Smaller reporting company | Yes |
| 2022-03-10 | 10-K | Emerging growth company | Yes |
| 2022-03-10 | 10-K | Well-known seasoned issuer | No |
| 2021-11-04 | 10-Q | Smaller reporting company | Yes |
| 2021-11-04 | 10-Q | Emerging growth company | Yes |
| 2021-08-05 | 10-Q | Smaller reporting company | Yes |
| 2021-08-05 | 10-Q | Emerging growth company | Yes |
| 2021-05-06 | 10-Q | Stock registered under Section 12(b) | Common Stock, $0.0001 par value per share · DYN · NASDAQ |
| 2021-05-06 | 10-Q | Shell company | Yes |
| 2021-05-06 | 10-Q | Smaller reporting company | Yes |
| 2021-05-06 | 10-Q | Emerging growth company | Yes |
| 2021-03-04 | 10-K | Public float as of 2020-06-30 | $0.00 |
| 2021-03-04 | 10-K | Stock registered under Section 12(b) | Common Stock, $0.0001 par value per share · DYN · NASDAQ |
| 2021-03-04 | 10-K | Smaller reporting company | Yes |
| 2021-03-04 | 10-K | Emerging growth company | Yes |
| 2021-03-04 | 10-K | Well-known seasoned issuer | No |
| 2020-11-05 | 10-Q | Stock registered under Section 12(b) | Common Stock, $0.0001 par value per share · DYN · NASDAQ |
| 2020-11-05 | 10-Q | Smaller reporting company | Yes |
| 2020-11-05 | 10-Q | Emerging growth company | Yes |
| 2020-11-05 | 10-Q | Current in its reporting | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |